Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema

Name: Retina Partners Midwest, P.C.
Address: 10300 N. Illinois St., Suite 1000, Carmel, IN, 46290, US
Telephone: 317-817-1000
Price range: NA